CAS: 356547-88-1 - Belimumab
Fórmula:Unspecified
- Sinónimos:
- Benlysta
- LymphoStat B
- Belimumab
- Immunoglobulin G1, anti-(human BLyS) (human monoclonal LymphoStat-B heavy chain), disulfide with human monoclonal LymphoStat-B λ-chain, dimer
- Immunoglobulin G1, anti-(human cytokine BAFF) (human monoclonal LymphoStat-B heavy chain), disulfide with human monoclonal LymphoStat-B λ-chain, dimer
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Belimumab REF: TM-T76957CAS: 356547-88-1 | SDS-PAGE:98.4%;SEC-HPLC:98.4% | A consultar | Vie 15 Nov 24 |
 | Belimumab REF: 3D-CLA1649CAS: 356547-88-1 | - - - | A consultar | Lun 25 Nov 24 |
Belimumab
CAS:356547-88-1
Belimumab, a human IgG1λ monoclonal antibody, blocks BAFF, treating lupus and related fatigue.
Pureza:
SDS-PAGE:98.4%;SEC-HPLC:98.4%
Forma y color:
Solid
Ref: TM-T76957
| 1mg | 48,00 € | ||
| 5mg | 94,00 € | ||
| 10mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 15 de Noviembre de 2024
Ref: 3D-CLA1649
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Lunes 25 de Noviembre de 2024
